| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 1001 | $6.03 | -3.52% | +1.68% | $362.62M €316.17M | 713.08K shrs $4.3M | ||
| 1002 | $10.55 | -4.52% | -1.48% | $362.44M €316.01M | 42.06K shrs $443.71K | ||
| 1003 | $3.83 | -4.49% | +2.12% | $361.24M €314.97M | 445.23K shrs $1.71M | ||
| 1004 | ¥6.46 | +0.47% | -1.75% | ¥2.62B $361.12M · €314.86M | 5.85M shrs ¥37.79M | ||
| 1005 |  OmniAb, Inc. OABI🇺🇸USD | $2.48 | -6.77% | +2.58% | $359.53M €313.48M | 493.43K shrs $1.22M | |
| 1006 | ¥22.71 | -3.24% | +0.00% | ¥2.61B $359.53M · €313.48M | 5.21M shrs ¥118.21M | ||
| 1007 | ¥5.60 | +2.00% | -3.32% | ¥2.6B $359.11M · €313.11M | 6.36M shrs ¥35.63M | ||
| 1008 | ¥33.32 | +0.48% | +8.44% | ¥2.6B $358.49M · €312.57M | 502.28K shrs ¥16.74M | ||
| 1009 |  Medtide Inc. 3880.HK🇭🇰HKD | HK$19.74 | -0.70% | -3.66% | HK$2.8B $358.29M · €312.39M | 102.5K shrs HK$2.02M | |
| 1010 | $7.03 | +0.29% | -0.62% | $357.82M €311.99M | 165.1K shrs $1.16M | ||
| 1011 | ₹190.10 | -0.94% | +1.41% | ₹29.8B $357.65M · €311.84M | 5.97K shrs ₹1.13M | ||
| 1012 | ₹189.88 | -1.07% | +1.69% | ₹29.77B $357.24M · €311.48M | 185.06K shrs ₹35.14M | ||
| 1013 | NT$75.70 | +1.47% | +2.29% | NT$11.35B $351.89M · €306.81M | 1.43M shrs NT$108.48M | ||
| 1014 | $4.58 | -4.58% | +20.78% | $351.2M €306.21M | 1.11M shrs $5.1M | ||
| 1015 | ¥13.40 | +0.60% | -7.84% | ¥2.53B $349.55M · €304.78M | 1.87M shrs ¥25.02M | ||
| 1016 | NT$63.10 | +0.16% | +0.80% | NT$11.28B $349.55M · €304.77M | 496.72K shrs NT$31.34M | ||
| 1017 | NT$41.90 | +1.82% | -7.53% | NT$11.1B $344.19M · €300.10M | 360.44K shrs NT$15.1M | ||
| 1018 | HK$13.49 | -12.97% | +0.23% | HK$2.68B $343.47M · €299.47M | 7.6K shrs HK$102.52K | ||
| 1019 | $4.37 | -8.58% | -9.55% | $343.14M €299.18M | 460.22K shrs $2.01M | ||
| 1020 | ¥9.69 | +0.00% | -6.97% | ¥2.48B $342.41M · €298.54M | 21.51M shrs ¥208.43M | ||
| 1021 | A$2.70 | -2.17% | -1.30% | A$526.59M $342.28M · €298.44M | 115.66K shrs A$312.27K | ||
| 1022 | $4.25 | -3.85% | +6.70% | $340.12M €296.55M | 215.58K shrs $916.2K | ||
| 1023 | ₩10440.00 | -4.57% | -0.39% | ₩471.63B $339.57M · €296.07M | 209.83K shrs ₩2.19B | ||
| 1024 | ¥23.91 | +0.00% | -1.05% | ¥2.46B $339.50M · €296.01M | 1.94M shrs ¥46.33M | ||
| 1025 | $16.52 | -1.02% | +17.47% | $338.31M €294.97M | 408.17K shrs $6.74M | ||
| 1026 | HK$2.28 | +0.00% | +0.44% | HK$2.64B $338.23M · €294.90M | 42K shrs HK$95.76K | ||
| 1027 | HK$3.64 | -2.93% | +2.50% | HK$2.64B $337.88M · €294.60M | 852.4K shrs HK$3.1M | ||
| 1028 | ₩9130.00 | -2.87% | -2.05% | ₩468.02B $336.98M · €293.81M | 91.72K shrs ₩837.43M | ||
| 1029 |  Kamada Ltd. KMDA.TA🇮🇱ILA | ₪0.22 | +1.31% | +6.75% | ₪1.25B $336.43M · €293.33M | 22.23K shrs ₪480.21K | |
| 1030 | $0.90 | +4.03% | +1.30% | $334.93M €292.03M | 439.1K shrs $396.94K | ||
| 1031 | ¥36.18 | +2.17% | +22.00% | ¥2.41B $332.86M · €290.22M | 495.4K shrs ¥17.92M | ||
| 1032 | $6.85 | -10.81% | +0.00% | $332.83M €290.19M | 356.92K shrs $2.44M | ||
| 1033 | HK$3.50 | +4.48% | -0.98% | HK$2.59B $331.21M · €288.78M | 292.3K shrs HK$1.02M | ||
| 1034 | ¥12.60 | +2.52% | -2.82% | ¥2.39B $329.85M · €287.60M | 2.53M shrs ¥31.89M | ||
| 1035 | HK$2.10 | -3.23% | -4.60% | HK$2.58B $329.70M · €287.47M | 512.8K shrs HK$1.08M | ||
| 1036 | ¥3.83 | +1.06% | -1.08% | ¥2.39B $329.66M · €287.43M | 21.76M shrs ¥83.33M | ||
| 1037 | $3.17 | -3.65% | -12.77% | $329.31M €287.12M | 1.24M shrs $3.93M | ||
| 1038 | $0.20 | +0.00% | -5.26% | $328.67M €286.57M | 770.83K shrs $154.16K | ||
| 1039 | $4.03 | -13.15% | +2.45% | $328.02M €286.00M | 1.02M shrs $4.1M | ||
| 1040 | $11.28 | -3.84% | +5.05% | $328M €285.99M | 129.1K shrs $1.46M | ||
| 1041 | ¥27.52 | +1.70% | +0.67% | ¥2.37B $327.25M · €285.33M | 969.1K shrs ¥26.67M | ||
| 1042 | C$12.72 | +0.00% | +19.50% | C$441.86M $326.97M · €285.09M | 12 shrs C$152.64 | ||
| 1043 | $22.25 | -6.00% | +2.91% | $326.59M €284.75M | 176.88K shrs $3.94M | ||
| 1044 |  Verastem, Inc. VSTM🇺🇸USD | $3.71 | -3.89% | -2.61% | $326.01M €284.25M | 3.03M shrs $11.23M | |
| 1045 | ¥25.62 | +0.95% | -4.29% | ¥2.35B $324.10M · €282.59M | 947.7K shrs ¥24.28M | ||
| 1046 | HK$1.21 | -3.20% | +2.73% | HK$2.53B $323.85M · €282.36M | 11.61M shrs HK$14.05M | ||
| 1047 | ¥9.79 | +0.62% | -9.47% | ¥2.34B $323.53M · €282.09M | 3.85M shrs ¥37.73M | ||
| 1048 | ¥7.72 | +1.18% | -2.37% | ¥2.34B $323.17M · €281.77M | 4.3M shrs ¥33.19M | ||
| 1049 |  Zura Bio Limited ZURA🇺🇸USD | $3.40 | -7.36% | +16.26% | $322.59M €281.27M | 4.93M shrs $16.77M | |
| 1050 | ₩29100.00 | -3.64% | -5.36% | ₩441.64B $317.98M · €277.25M | 65.1K shrs ₩1.89B | ||
| 1051 | ¥10.32 | +2.08% | -6.39% | ¥2.3B $317.71M · €277.01M | 2.17M shrs ¥22.42M | ||
| 1052 | NT$154.00 | -3.14% | +9.76% | NT$10.23B $317.14M · €276.52M | 133.25K shrs NT$20.52M | ||
| 1053 | C$16.84 | +0.54% | +2.08% | C$427.59M $316.42M · €275.88M | 8.24K shrs C$138.74K | ||
| 1054 | ₩48800.00 | -2.40% | -23.91% | ₩438.96B $316.05M · €275.57M | 42.44K shrs ₩2.07B | ||
| 1055 | ¥6.85 | +1.18% | -5.24% | ¥2.29B $315.85M · €275.39M | 5.3M shrs ¥36.3M | ||
| 1056 | NT$105.00 | -19.85% | -2.80% | NT$10.18B $315.71M · €275.27M | 2.63M shrs NT$276.13M | ||
| 1057 | ¥6.90 | +1.32% | -6.53% | ¥2.28B $315.13M · €274.76M | 6.13M shrs ¥42.33M | ||
| 1058 | ₩4435.00 | -1.99% | +0.49% | ₩437.58B $315.06M · €274.70M | 385.25K shrs ₩1.71B | ||
| 1059 |  REGENXBIO Inc. RGNX🇺🇸USD | $6.08 | -11.63% | +31.56% | $314.32M €274.06M | 1.59M shrs $9.68M | |
| 1060 | $2.42 | -2.42% | +0.41% | $311.39M €271.50M | 673.62K shrs $1.63M | ||
| 1061 | $5.46 | -6.19% | +5.77% | $311.19M €271.33M | 874.63K shrs $4.78M | ||
| 1062 | HK$2.33 | +0.00% | +1.72% | HK$2.43B $311.06M · €271.22M | 942K shrs HK$2.19M | ||
| 1063 | ₹536.35 | -1.44% | -3.16% | ₹25.84B $310.06M · €270.34M | 6.84K shrs ₹3.67M | ||
| 1064 | ₹534.85 | -1.55% | -2.22% | ₹25.77B $309.19M · €269.58M | 98.28K shrs ₹52.57M | ||
| 1065 | ¥6.46 | +0.47% | -8.67% | ¥2.24B $309.12M · €269.52M | 5.37M shrs ¥34.69M | ||
| 1066 | $4.30 | -2.93% | -13.49% | $308.41M €268.91M | 549.42K shrs $2.36M | ||
| 1067 |  Cellectis S.A. CLLS🇺🇸USD | $3.06 | -0.91% | +1.38% | $307.87M €268.43M | 46.87K shrs $143.42K | |
| 1068 | ₹363.05 | -2.54% | +8.83% | ₹25.56B $306.73M · €267.44M | 13.45K shrs ₹4.88M | ||
| 1069 | ₹362.85 | -2.55% | +5.76% | ₹25.55B $306.56M · €267.29M | 2.21K shrs ₹803.71K | ||
| 1070 | HK$21.00 | +0.57% | +3.74% | HK$2.39B $306.08M · €266.87M | 19.9K shrs HK$417.9K | ||
| 1071 | $5.64 | -3.42% | +18.47% | $303.9M €264.97M | 188.28K shrs $1.06M | ||
| 1072 | $2.39 | -10.82% | -21.03% | $303.72M €264.81M | 490.87K shrs $1.17M | ||
| 1073 | $3.81 | -6.62% | +12.10% | $303.45M €264.58M | 219.63K shrs $836.8K | ||
| 1074 |  Invivyd, Inc. IVVD🇺🇸USD | $1.03 | -7.21% | -8.66% | $303.45M €264.57M | 4.96M shrs $5.11M | |
| 1075 | ¥3.37 | -0.88% | -12.30% | ¥2.2B $303.17M · €264.34M | 10.66M shrs ¥35.93M | ||
| 1076 | $1.74 | -9.84% | +1.55% | $302.38M €263.64M | 4.31M shrs $7.5M | ||
| 1077 | HK$2.37 | -0.84% | +1.44% | HK$2.36B $302.30M · €263.58M | 2.16M shrs HK$5.11M | ||
| 1078 | $8.70 | -5.02% | +0.39% | $302.21M €263.50M | 168.18K shrs $1.46M | ||
| 1079 | $1.63 | -6.86% | +0.62% | $302.01M €263.33M | 860.33K shrs $1.4M | ||
| 1080 | HK$3.43 | +0.88% | +32.62% | HK$2.35B $301.30M · €262.70M | 2.75M shrs HK$9.43M | ||
| 1081 | $2.75 | -5.82% | +1.44% | $300.28M €261.82M | 2.55M shrs $7.02M | ||
| 1082 | kr 10.96 | +3.79% | +0.50% | kr 3.09B $299.30M · €260.96M | 848.05K shrs kr 9.29M | ||
| 1083 | A$9.13 | +2.24% | +0.59% | A$460.41M $299.26M · €260.93M | 48.88K shrs A$446.26K | ||
| 1084 | kr 30.84 | -2.65% | +3.78% | kr 3.08B $298.35M · €260.13M | 191.67K shrs kr 5.91M | ||
| 1085 | ¥13.51 | +1.96% | -4.69% | ¥2.16B $298.30M · €260.09M | 2.08M shrs ¥28.04M | ||
| 1086 | £22.60 | +0.44% | -20.00% | £234.54M $297.86M · €259.71M | 708.48K shrs £16.01M | ||
| 1087 | $1.19 | -1.65% | +4.00% | $296.66M €258.66M | 962.44K shrs $1.15M | ||
| 1088 |  IMBiologics 493280.KQ🇰🇷KRW | ₩27800.00 | -7.33% | -4.15% | ₩410.78B $295.76M · €257.87M | 37.57K shrs ₩1.04B | |
| 1089 | ¥22.35 | +0.86% | -5.06% | ¥2.14B $295.06M · €257.27M | 2.53M shrs ¥56.65M | ||
| 1090 | ₹2368.65 | -0.60% | +11.60% | ₹24.58B $294.93M · €257.15M | 6.98K shrs ₹16.54M | ||
| 1091 |  ImmuneOncia 424870.KQ🇰🇷KRW | ₩4490.00 | +1.47% | -5.96% | ₩409.46B $294.81M · €257.05M | 605.14K shrs ₩2.72B | |
| 1092 | ₩37650.00 | +0.40% | -6.80% | ₩409.33B $294.72M · €256.96M | 127.38K shrs ₩4.8B | ||
| 1093 | ¥12.66 | +1.69% | -5.58% | ¥2.13B $294.05M · €256.38M | 2.55M shrs ¥32.26M | ||
| 1094 | ₩6790.00 | -0.59% | +7.17% | ₩408.05B $293.80M · €256.16M | 58.14K shrs ₩394.8M | ||
| 1095 | $4.20 | -1.64% | +5.25% | $293.21M €255.65M | 478.49K shrs $2.01M | ||
| 1096 | ¥7.74 | +2.38% | +0.47% | ¥2.12B $293.09M · €255.55M | 8.54M shrs ¥66.07M | ||
| 1097 | $6.17 | -9.93% | +44.43% | $291.44M €254.10M | 158.92K shrs $980.55K | ||
| 1098 | ¥27.55 | +1.92% | -6.41% | ¥2.11B $290.83M · €253.57M | 1.09M shrs ¥29.9M | ||
| 1099 | £331.50 | +0.00% | +0.15% | £228.89M $290.69M · €253.45M | 36.24K shrs £12.01M | ||
| 1100 | ¥5.61 | +1.45% | -5.33% | ¥2.1B $289.64M · €252.54M | 6.24M shrs ¥35.02M |
Browse by Country
Europe
Asia